Raza Ahmed, Chaudhary Muhammad Ajmal, Mushtaq Asma, Khan Asad Aslam
Ahmed Raza, MBBS, FCPS, FPO Department of Pediatric Ophthalmology, The University of Child Health Sciences, Lahore, Pakistan.
Muhammad Ajmal Chaudhary, MBBS, DOMS, MCPS, FCPS, FPO Department of Pediatric Ophthalmology, Sheikh Zayed Medical College, Rahim Yar Khan, Pakistan.
Pak J Med Sci. 2024 Oct;40(9):1937-1940. doi: 10.12669/pjms.40.9.8788.
To determine the efficacy of modified combined trabeculotomy-trabeculectomy (CTT) with mitomycin-C (MMC) versus conventional CTT with MMC for intraocular pressure (IOP) reduction in patients with primary congenital glaucoma (PCG).
This interventional study was carried out in The Institute of Ophthalmology, Lahore from January 2018 to June 2019. We included 70 patients of either gender, with the age range from birth to ten years and with PCG having IOP >30 mm Hg. These patients were divided in groups A and B with 35 patients in each group. Patients in Group-A underwent modified CTT with MMC and in Group-B conventional CTT with MMC was carried out.
The mean age of our patients was 15.17 ± 12.39 months. Regarding gender, 57 (81.4%) were males and 13 (18.6%) were females. Baseline mean IOP in Group-A was 32.49 ± 1.01 mm Hg whereas in Group-B mean IOP was 31.97 ± 1.04 mm Hg. After one month, the mean IOP was 27.60 ± 1.72 mm Hg in Group-A, whereas mean IOP was 27.40 ± 1.82 mmHg in Group-B. After three months, the mean IOP was 21.63 ± 1.09 mm Hg in Group-A, whereas 20.97 ± 1.12 mm Hg in Group-B. In Group-A efficacy was achieved in 14 (40%) patients whereas in Group-B efficacy was achieved in 25 (71.4%) patients.
Our study revealed that conventional CTT with MMC showed better efficacy than modified CTT with MMC for reduction of IOP in PCG.
确定改良小梁切开术-小梁切除术(CTT)联合丝裂霉素C(MMC)与传统CTT联合MMC降低原发性先天性青光眼(PCG)患者眼压(IOP)的疗效。
本干预性研究于2018年1月至2019年6月在拉合尔眼科研究所进行。我们纳入了70例患者,不限性别,年龄范围从出生到10岁,患有PCG且IOP>30 mmHg。这些患者被分为A组和B组,每组35例。A组患者接受改良CTT联合MMC治疗,B组患者接受传统CTT联合MMC治疗。
我们患者的平均年龄为15.17±12.39个月。在性别方面,57例(81.4%)为男性,13例(18.6%)为女性。A组基线平均IOP为32.49±1.01 mmHg,而B组平均IOP为31.97±1.04 mmHg。1个月后,A组平均IOP为27.60±1.72 mmHg,而B组平均IOP为27.40±1.82 mmHg。3个月后,A组平均IOP为21.63±1.09 mmHg,而B组为20.97±1.12 mmHg。A组有14例(40%)患者眼压得到控制,而B组有25例(71.4%)患者眼压得到控制。
我们的研究表明,传统CTT联合MMC在降低PCG患者眼压方面比改良CTT联合MMC显示出更好的疗效。